COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 596: Articles 5951-5960  | Next

Omicron sublineage BA.2.75.2 exhibits extensive escape from neutralising antibodies
Sheward, D. J., Kim, C., Fischbach, J., Muschiol, S., Ehling, R. A., Björkström, N. K., Karlsson Hedestam, G. B., Reddy, S. T., Albert, J., Peacock, T. P., Murrell, B.
10.1101/2022.09.16.508299 — Posted: 2022-09-16
Genome characterization of monkeypox cases detected in India: Identification of three sub clusters among A.2 lineage
Shete, A. M., Yadav, P. D., Kumar, A., Patil, S., Patil, D. Y., Joshi, Y., Majumdar, T., Relhan, V., Sahay, R. R., Vasu, M., Gawande, P., Verma, A., Kumar, A., Dhakad, S., Krishnan, A. B., Chenayil, S., Kumar, S., Abraham, P.
10.1101/2022.09.16.507742 — Posted: 2022-09-16
SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF
Christ, W., Kapell, S., Mermelekas, G., Evertsson, B., Sork, H., Bazaz, S., Gustafsson, O., Sobkowiak, M. J., Cardenas, E. I., Villa, V., Ricciarelli, R., Sandberg, J. K., Bergquist, J., Sturchio, A., Svenningsson, P., Malm, T., Espay, A. J., Pernemalm, M., Linden, A., Klingstrom, J., EL Andaloussi, S., Ezzat, K.
10.1101/2022.09.15.508120 — Posted: 2022-09-16
Imprinted SARS-CoV-2 humoral immunity induces converging Omicron RBD evolution
Cao, Y., Jian, F., Wang, J., Yu, Y., Song, W., Yisimayi, A., Wang, J., An, R., Zhang, N., Wang, Y., Wang, P., Zhao, L., Sun, H., Yu, L., Yang, S., Niu, X., Xiao, T., Gu, Q., Shao, F., Hao, X., Xu, Y., Jin, R., Wang, Y., Xie, X. S.
10.1101/2022.09.15.507787 — Posted: 2022-09-16
SARS-CoV-2 infection of human neurons requires endosomal cell entry and can be blocked by inhibitors of host phosphoinositol-5 kinase
Kettunen, P. P., Lesnikova, A., Räsänen, N., Ojha, R., Palmunen, L., Laakso, M., Lehtonen, S., Kuusisto, J., Pietiläinen, O., Vapalahti, O., Koistinaho, J., Rolova, T., Balistreri, G.
10.1101/2022.09.14.508057 — Posted: 2022-09-16
The impact of access to financial services on mitigating COVID-19 mortality globally
Watkins, T. A., Nguyen, K., Ali, H., Gummakonda, R., Pelman, J., Taracena, B.
10.1101/2022.09.12.22279872 — Posted: 2022-09-16
Rationale, Design, and Baseline Characteristics of the VALIANT (COVID-19 in Older Adults: A Longitudinal Assessment) Cohort
Cohen, A. B., McAvay, G., Geda, M., Chattopadhyay, S., Lee, S., Acampora, D., Araujo, K., Charpentier, P., Gill, T. M., Hajduk, A., Ferrante, L.
10.1101/2022.09.14.22279932 — Posted: 2022-09-15
Evaluation of long-term sequelae by cardiopulmonary exercise testing 12 months after hospitalization for critical COVID-19
Noureddine, S., Roux, P., Laurent, L., Ritter, O., Dolla, P., Karaer, S., Claude, F., Westeel, V., Barnig, C.
10.1101/2022.09.12.22279779 — Posted: 2022-09-15
A Cross-Sectional Study of Quantitative CT Measurements Associated with the Diffusion Capacity of the Lung in Recovered COVID-19 Patients with Clear Chest CTs
Wen, H., Kanth, S. M., Huapaya Carrera, J. A., Sun, J., Do, M., Chen, M. Y., Malayeri, A. A., Suffredini, A. F.
10.1101/2022.09.13.22279543 — Posted: 2022-09-15
Severe fatigue as symptom of long COVID is characterized by increased expression of inflammatory genes in monocytes, increased serum pro-inflammatory cytokines, and increased CD8+ T-lymphocytes. A putative dysregulation of the immune-brain axis, the coagulation process, and auto-inflammation to explain the diversity of long COVID symptoms
Berentschot, J. C., Drexhage, H. A., Aynekulu Mersha, D. A., Wijkhuijs, A. J., GeurtsvanKessel, C. H., Koopmans, M. P., Voermans, J., Heijenbrok-Kal, M. H., Bek, L. M., Ribbers, G. M., van den Berg-Emons, R. J., Aerts, J. G., Dik, W. A., Hellemons, M. E.
10.1101/2022.09.15.22279970 — Posted: 2022-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).